Home › Cancro colorettale › Arizona › Gilbert
Studi clinici su Cancro colorettale a Gilbert, AZ
9 studi su Cancro colorettale cercano partecipanti presso sedi a Gilbert e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
In reclutamentoFase 1
- Research Site, Gilbert
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Banner MD Anderson Cancer Center, Gilbert
- Ironwood Cancer & Research Centers, Gilbert
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Banner Health, Gilbert
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
In reclutamentoFase 3
- Banner MD Anderson Cancer Center, Gilbert
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
In reclutamentoFase 3
- Banner MD Anderson Cancer Center, Gilbert
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
In reclutamentoFase 3
- Banner MD Anderson Cancer Center, Gilbert
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
In reclutamentoFase 1/2
- Banner Health- MD Anderson Cancer Center, Gilbert
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Banner Health, Gilbert
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY77 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA38 studi
- Seattle, WA34 studi
Altri studi a Gilbert
- Cancro del polmone non a piccole cellule12 studi
- Cancro al seno9 studi
- Cancro ai polmoni8 studi
- Cancro (tutti i tipi)8 studi
- Carcinoma a cellule squamose della testa e del collo6 studi
- Cancro metastatico6 studi
- Mieloma multiplo6 studi
- Insufficienza cardiaca6 studi
- Malattie cardiovascolari6 studi
- Cancro della vescica6 studi
- Linfoma non Hodgkin5 studi
- Linfoma diffuso a grandi cellule B5 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.